Arch Biopartners Inc. (ACHFF)
Develops medicines to prevent kidney damage during and after surgery.
$0.59+0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-52.8%
The outlook
Arch Biopartners is trading near the lower end of its 52-week range, with price action mixed against its moving averages. Analyst coverage appears thin on available data. The overall sentiment sits neutral, reflecting uncertainty around the stock's near-term direction.
What’s behind the score
Price trendMixed vs its moving averages
52-week range31% of the way from its 52-week low to high
Market cap
$40.1M
52-wk high
$1.27
52-wk low
$0.29
50-day avg
$0.47
200-day avg
$0.61
Trailing P/E
—